ADMA INVESTIGATION UPDATE: ADMA Biologics Investors are Notified of Securities Fraud Investigation into Auditor Resignation; Contact BFA Law if You Lost Money (Nasdaq:ADMA)
October 19, 2024 06:28 ET
|
Bleichmar Fonti & Auld
ADMA Biologics, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.
ADMA FRAUD NOTICE: Lost Money on Your ADMA Biologics, Inc. Securities? Contact BFA Law about its Investigation into the Company after Auditor Resigns (Nasdaq:ADMA)
October 17, 2024 06:05 ET
|
Bleichmar Fonti & Auld
ADMA Biologics, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm
October 15, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against ADMA Biologics, Inc....
ADMA LEGAL NOTICE: ADMA Biologics, Inc. is being Investigated for Securities Fraud after Auditor Resignation; Investors with Losses are Urged to Contact BFA Law (Nasdaq:ADMA)
October 15, 2024 06:11 ET
|
Bleichmar Fonti & Auld
ADMA Biologics, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.
ADMA SHAREHOLDER ALERT: ADMA Biologics, Inc. is Under Investigation for Securities Fraud after Auditor Resignation and 20% Stock Drop; Investors are Urged to Contact BFA Law (Nasdaq:ADMA)
October 13, 2024 07:23 ET
|
Bleichmar Fonti & Auld
ADMA Biologics, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.
ADMA FRAUD ALERT: BFA Law is Investigating ADMA Biologics, Inc. for Securities Fraud after Stock Drops 20%; Investors with Losses are Urged to Contact the Firm (Nasdaq:ADMA)
October 11, 2024 06:35 ET
|
Bleichmar Fonti & Auld
ADMA Biologics, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.
ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System
August 10, 2021 16:30 ET
|
ADMA Biologics, Inc.
RAMSEY, N.J. and BOCA RATON, Fla. and CONYERS, Ga., Aug. 10, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to...